Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test – GenomeWeb

NEW YORK Aspira Women's Health said Thursday that is has entered a collaborative research agreement with Baylor Genetics to codevelop an early detection test for ovarian cancer.

Austin, Texas-based Aspira said it will bring its experience in recruitment of patient samples and assay development to the collaboration.

Go here to read the rest:
Aspira Collaborating With Baylor Genetics on Ovarian Cancer Early Detection Test - GenomeWeb

Related Posts